1. Home
  2. ADMA vs SPR Comparison

ADMA vs SPR Comparison

Compare ADMA & SPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADMA
  • SPR
  • Stock Information
  • Founded
  • ADMA 2004
  • SPR 1927
  • Country
  • ADMA United States
  • SPR United States
  • Employees
  • ADMA N/A
  • SPR N/A
  • Industry
  • ADMA Biotechnology: Biological Products (No Diagnostic Substances)
  • SPR Military/Government/Technical
  • Sector
  • ADMA Health Care
  • SPR Industrials
  • Exchange
  • ADMA Nasdaq
  • SPR Nasdaq
  • Market Cap
  • ADMA 4.1B
  • SPR 3.9B
  • IPO Year
  • ADMA N/A
  • SPR 2006
  • Fundamental
  • Price
  • ADMA $21.31
  • SPR $33.47
  • Analyst Decision
  • ADMA Strong Buy
  • SPR Hold
  • Analyst Count
  • ADMA 4
  • SPR 13
  • Target Price
  • ADMA $22.50
  • SPR $36.00
  • AVG Volume (30 Days)
  • ADMA 3.7M
  • SPR 1.5M
  • Earning Date
  • ADMA 05-08-2025
  • SPR 05-06-2025
  • Dividend Yield
  • ADMA N/A
  • SPR N/A
  • EPS Growth
  • ADMA N/A
  • SPR N/A
  • EPS
  • ADMA 0.81
  • SPR N/A
  • Revenue
  • ADMA $426,454,000.00
  • SPR $6,316,600,000.00
  • Revenue This Year
  • ADMA $18.45
  • SPR $25.91
  • Revenue Next Year
  • ADMA $26.96
  • SPR $14.67
  • P/E Ratio
  • ADMA $26.31
  • SPR N/A
  • Revenue Growth
  • ADMA 65.16
  • SPR 4.44
  • 52 Week Low
  • ADMA $6.01
  • SPR $27.00
  • 52 Week High
  • ADMA $23.64
  • SPR $37.08
  • Technical
  • Relative Strength Index (RSI)
  • ADMA 60.16
  • SPR 51.80
  • Support Level
  • ADMA $17.30
  • SPR $29.25
  • Resistance Level
  • ADMA $22.25
  • SPR $33.27
  • Average True Range (ATR)
  • ADMA 1.50
  • SPR 1.39
  • MACD
  • ADMA 0.16
  • SPR 0.13
  • Stochastic Oscillator
  • ADMA 83.62
  • SPR 82.95

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.

About SPR Spirit Aerosystems Holdings Inc.

Spirit AeroSystems manufactures aerostructures, particularly fuselages, cockpits, wing sections, engine pylons, and nacelles for commercial and military aircraft. The company was spun out of Boeing in 2005 to become the largest independent supplier of aerostructures for commercial aircraft. Boeing and Airbus are the firm's primary customers—Boeing represented roughly 60% and Airbus roughly 20% of revenue in recent years. The company is highly exposed to Boeing's beleaguered 737 program, which accounts for nearly half the company's revenue. The company plans to be acquired by and reintegrated into Boeing in mid-2025.

Share on Social Networks: